Which oral hypoglycaemic for gestational diabetes?
Posted by Akheel Syed on 23 January, 2015
“Latest evidence favours metformin over glibenclamide, but there’s more work to do on both agents.”
Read all about it in The BMJ
Editorial by David Sacks, BMJ 2015;350:h177.
Systematic review and meta-analysis by Montserrat Balsells et al., BMJ 2015;350:h102